A System Wide Diagnosis For America’s $5 Trillion Healthcare Problem
The healthcare landscape is undergoing significant changes, from legislative actions to strategic shifts in policy. The current system is plagued by broken incentives that prioritize profit over outcomes. In order to truly transform healthcare delivery in the United States, a new business model is needed—one that aligns incentives, promotes transparency, and holds all stakeholders accountable for the value they provide.
Currently, each segment of the healthcare ecosystem operates independently, focused on maximizing revenue without considering the overall impact on health outcomes or long-term sustainability. This siloed behavior has led to a system that rewards inefficiency and punishes reform. Hospitals invest in expensive facilities, insurers profit from denying claims, PBMs chase rebates that inflate drug costs, and pharmaceutical manufacturers face barriers to promoting cheaper generic drugs. Even programs like Medicaid and 340B have strayed from their original purpose and become revenue tools.
To address these systemic issues, a fundamental shift in the healthcare business model is necessary. The focus must move from volume to outcomes, with a renewed emphasis on accountability, transparency, and value-based care. CMS’s new strategic direction is a step in the right direction, emphasizing site-neutral payment and accountability in care delivery. However, true change requires more than just policy guidance—it necessitates a shift in how care is delivered and how stakeholders are incentivized.
Providers must invest in models that prioritize results and embrace new care delivery methods, particularly in underserved areas. Payers need to move from cost control to value management, adopting transparency and aligning financial incentives with long-term health outcomes. PBMs must reform their rebate-driven model and focus on rewarding value over volume in drug pricing. And programs like Medicare, Medicaid, and 340B must be scrutinized to ensure that public healthcare funds are used efficiently and effectively.
Ultimately, a new healthcare business model grounded in outcomes, transparency, and competition is needed to drive meaningful change in the industry. By holding stakeholders accountable for creating and communicating value, we can achieve better results for patients, taxpayers, and healthcare companies. While the path forward may be challenging, it is clear that a new approach is necessary to truly transform the healthcare system in the United States.
